What is the Consensus Value of Patients’ Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease
Key Points
Patients express varying levels of treatment-risk tolerance for inflammatory bowel disease, emphasizing distinct preferences.
The study highlights that understanding these preferences is crucial for tailored treatment strategies, enhancing patient satisfaction.
Observational analysis collecting stated-preference data from patients was conducted, emphasizing the importance of personalized care.
Findings may enable healthcare providers to offer better treatment options aligned with patient values, improving outcomes.
Like
Bookmark
Share
Like
Bookmark
Share
What is the Consensus Value of Patients’ Treatment-Risk Tolerance? Assessing a Stated-Preference Evidence Base for Inflammatory Bowel Disease | Synapse